Gabelli Healthcare & WellnessRx Trust

The Gabelli Healthcare & WellnessRx Trust declared a cash distribution of $0.17 per share, payable on June 23, 2026, to shareholders of record on June 15, 2026. The Fund intends to pay quarterly distributions, with a potential adjusting distribution in December. For 2026, estimated components of the distribution include 6% from net investment income, 63% from net capital gains, and 31% as a return of capital on a book basis.

Gabelli Healthcare & WellnessRx Trust announced that Mario J. Gabelli, Trustee, Chairman, and Chief Investment Officer, is recovering after a medical incident on March 19, 2026, though his return timeline is undetermined. In response, GAMCO Investors, Inc., the parent company of the Fund's adviser, activated its succession plan on March 22, 2026. Christopher J. Marangi was named President of GAMCO, and he will lead day-to-day operations alongside co-CEO Douglas R. Jamieson. The Fund's portfolio management team will be led by Co-Chief Investment Officers Kevin V. Dreyer and Christopher J. Marangi during Mr. Gabelli's absence.